Rubius Therapeutics competitorsClear all

Rubius Therapeutics's top competitors include ImCheck Therapeutics, Kymera Therapeutics and MedDay.
Rubius Therapeutics
Rubius Therapeutics
Rubius is developing a new class of drugs, Red-Cell Therapeutics™.
ImCheck Therapeutics
ImCheck Therapeutics
ImCheck Therapeutics is a biotech company developing the next generation of immune checkpoint modulators .
Kymera Therapeutics
Kymera Therapeutics
Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.
MedDay
MedDay
MedDay is a biotechnology company specializing in therapeutics for the treatment of neuro-metabolic diseases.
Founding Date
Founding Date
2013
Founding Date
2015
Founding Date
2017
Founding Date
2011
Type
Type
Public
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Cambridge, US HQ
Smithfield, US
Locations
Marseille, FR HQ
Locations
Cambridge, US HQ
Locations
Clichy, FR HQ
Paris, FR
Boston, US
Employees
Employees
17423% increase
Employees
393% increase
Employees
652% increase
Employees
745% decrease
Twitter followers
Twitter followers
993
Twitter followers
389
Twitter followers
1.7 k
Twitter followers
229
Number of tweets (last 30 days)
Number of tweets (last 30 days)
18
Number of tweets (last 30 days)
3
Number of tweets (last 30 days)
13
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
4.6
Average likes per tweet (last 30 days)
3.7
Average likes per tweet (last 30 days)
8.9
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
92.31%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
278156
Alexa Website Rank
N/A
Alexa Website Rank
395272
Alexa Website Rank
399748

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 53.2m (12 months ago)
Latest funding round
$ 102m (9 months ago)
Latest funding round
$ 38.5m (over 4 years ago)
Total funding raised
Total funding raised
$ 245m
Total funding raised
$ 76.1m
Total funding raised
$ 197m
Total funding raised
$ 48.9m
For sources of this data, please see the company profile

View company profiles

ImCheck Therapeutics
HQ
Marseille, FR
Employees
39↑ 3% increase

ImCheck Therapeutics is a biotech company developing the next generation of immune checkpoint modulators .

View company
Kymera Therapeutics
HQ
Cambridge, US
Employees
65↑ 2% increase

Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.

View company
MedDay
HQ
Clichy, FR
Employees
74↓ 5% decrease

MedDay is a biotechnology company specializing in therapeutics for the treatment of neuro-metabolic diseases.

View company